Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.3294
-0.0109 (-3.20%)
Jan 20, 2026, 4:00 PM EST - Market closed
Iterum Therapeutics Employees
Iterum Therapeutics had 9 employees as of December 31, 2024. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
$43,333
Profits / Employee
-$2,995,667
Market Cap
17.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 9 | -5 | -35.71% |
| Dec 31, 2023 | 14 | 0 | - |
| Dec 31, 2022 | 14 | 1 | 7.69% |
| Dec 31, 2021 | 13 | 6 | 85.71% |
| Dec 31, 2020 | 7 | -37 | -84.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ITRM News
- 4 weeks ago - Iterum Therapeutics Provides Business Update - GlobeNewsWire
- 2 months ago - Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Iterum Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 - GlobeNewsWire
- 3 months ago - Iterum Therapeutics to Present Data at IDWeek 2025 - GlobeNewsWire
- 5 months ago - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - GlobeNewsWire
- 6 months ago - Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Iterum Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewsWire